WebApr 13, 2024 · 此外,最近观察到对crbn或vhl的protacs的耐药性。 而尚未开发的细胞或组织类型特异性e3连接酶将是一种新型protac的研究基础,它可以以空间特异性的方式控制某种蛋白质的降解。因此,新型e3连接酶配体的发现将是一个重要的研究目标,以扩大protacs的应 … Web西安齐岳生物提供科研级别4-Hydroxy-thalidomide,halidomide-4-OH,Cereblon ligand 2,E3 ligase Ligand 2,仅供科研,不可用于人体,如有需求请与我们联系!
IJMS Free Full-Text Small-Molecule Inhibitors and Degraders ...
WebCereblon (CRBN) is a substrate recognition protein in the E3-ligase ubiquitin complex. The binding target of CRBN varies according to tissues and cells, and the protein regulates various biological functions by regulating tissue-specific targets. As new endogenous targets of CRBN have been identifie … WebSep 6, 2024 · Cereblon (CRBN) is an E3 ubiquitin ligase substrate receptor that is involved in cancer cell death, although its regulation is poorly understood. Here, the authors show … clowes concrete sealers and coatings
Discovery of CRBN as a target of thalidomide: a breakthrough for ...
Web泛素连接酶表提供 E3 泛素连接酶及其底物(已知时)、相应参考文献的列表。 泛素连接酶表 非常感谢哈佛大学医学院贝斯以色列女执事医疗中心的 Wenyi Wei 教授贡献这个表格。 WebApr 13, 2024 · 此外,最近观察到对crbn或vhl的protacs的耐药性。 而尚未开发的细胞或组织类型特异性e3连接酶将是一种新型protac的研究基础,它可以以空间特异性的方式控制 … WebFeb 8, 2024 · The binding of thalidomide derivatives to CRBN, a substrate recognition receptor for Cullin 4 RING E3 ubiquitin ligase (CRL4), induces the recruitment of non-native substrates to CRL4 CRBN and their subsequent degradation. This discovery was a breakthrough in the current rapid development of protein-degrading agents because … caberston construction